Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

A new compound shows promise as a topical treatment for hair loss.

Afatinib often causes skin problems that need proactive management.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Cancer treatments often cause skin, nail, and hair problems.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Brepocitinib reduces interferon signaling in hidradenitis suppurativa patients.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Isoxazole 9 (ISX9) may help regrow hair by activating certain cell signals.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.